Daily notes / October 19, 2026
Bruce Brown reported a Magnera open-market purchase on Form 4
Written by a model from the facts OQRO holds and checked against them, sentence by sentence of . Published . 3 min read.

The short answer
Bruce Brown, a Magnera director, reported buying 4,235 shares at $11.81 each in an open-market transaction dated May 29, 2025. The Form 4 was filed on Oct 19, 2026, 508 days later, and reports a post-purchase holding of 16,555 shares. OQRO’s available records show limited purchase history for comparison.
What did Bruce Brown report in the Form 4?
The SEC Form 4 identifies Bruce Brown as a director and reports an open-market purchase of 4,235 Magnera (MAGN) shares at $11.81 each. The transaction date was May 29, 2025; the filing date was Oct 19, 2026, 508 days later.
The filing puts Brown’s holding after the purchase at 16,555 shares. The reported increase over the estimated holding before the purchase was about 34.4%. The filing reports the transaction and holding, but does not state why the purchase was made.
What is the timing around the filing?
The data provider lists Nov 17, 2026 as Magnera’s next results date, 29 days after the filing date. The listed date can change.
General background is that many companies allow insiders to trade only in a window that opens after results; a transaction can also follow an option exercise, a tax bill or a pre-arranged plan. A Form 4 does not establish which, if any, of these circumstances applies to Brown’s purchase.
How does the purchase compare with other reported activity?
OQRO holds no other open-market purchases by Brown in the 365 days to Oct 19, 2026. OQRO does not hold enough history on Brown to say whether this was a first purchase. Only 0 of Brown’s disclosed purchases have had 90 days since they were reported, too few for OQRO to show a result.
OQRO also has no other open-market purchases at Magnera on record in the 455 days to Oct 19, 2026. These comparisons use only filings held by OQRO; they do not establish that no other activity occurred.
What other filings and coverage are on record?
For the quarter ended Jun 30, 2026, 13F filings show the largest positions that grew included Thompson Siegel & Walmsley LLC, which increased its holding to 75,542 shares, and Jacobs Levy Equity Management, Inc, which increased its holding to 76,709 shares. The largest positions that shrank included Weiss Asset Management LP and ING Groep NV, both sold out. A 13F is a quarter-end snapshot and does not give a trade date.
Magnera filed a Form 8-K on Feb 3, 2026, Item 5.02, 250 days after the purchase date. OQRO classes it as reporting a change to a top executive or board member. The company’s opening sentence says: “On January 29, 2026, Erin Maile was appointed by the Board of Directors of Magnera Corporation (the 'Company') as Executive Vice President, Chief Accounting Officer, effective February 2, 2026.”
A Form 8-K on Nov 19, 2025, Item 2.02, 174 days after the transaction date, is classified by OQRO as reporting results. A Form 8-K on Oct 2, 2025, Item 5.02, 126 days after the transaction date, is classified as reporting a change to a top executive or board member. Its opening sentence says Magnera announced the departure of certain officers; the sentence identifies Eileen L. Beck as Executive Vice President and states an effective date of December 31, 2025, before ending with “Hu...” in the supplied text.
What headlines appeared around the purchase?
Finnhub lists “Magnera Q3 2026 Earnings Call: Complete Transcript”, published by Benzinga on Oct 9, 2026; “Magnera Announces Successful Commissioning of New Blown Film Production Line in Dombühl, Germany”, published by Yahoo on Oct 5, 2026; and “Magnera Corporation: Executing But Abandoned”, published by SeekingAlpha on Aug 13, 2026. These are headlines as listed by the outlets; OQRO has not checked them or summarized the articles.
What this does not tell you?
A Form 4 reports a transaction; it does not say why it was made. Some purchases and sales follow trading windows or pre-arranged plans, and OQRO notes a plan only when a filing footnote says so. The available records do not establish which circumstances apply to this purchase.
An 8-K item says what the company reported, not what it means for the share price. OQRO’s comparisons use only filings it holds, and this article describes public filings; it is not investment advice. More company filing context is available on Magnera on OQRO.
Sources
A model wrote this page from the facts OQRO holds; every number, date, name and link in it was checked against those facts before publication, and a text that failed the check was not published. It describes what was filed, not why, and it is not investment advice. How OQRO treats data
Explore the data
More daily notes
- Chernett Jorey reported an Exagen share purchase on Form 4
- Robert Nelsen reported a City Therapeutics open-market purchase
- Control Empresarial reported a Talos Energy share sale on Form 4
- Harel filed a Schedule 13G reporting a 5.2% stake in Elbit Systems
- JP Sailing Capital filed a Schedule 13G on Nextcure
- Norbel Investments filed a Schedule 13G on Papa John's Pizza